Tris Pharma

Tris Pharma is a pharmaceutical company committed to developing and delivering innovative therapies for the treatment of ADHD, pain, addiction, and other diseases of the central nervous system. Using proprietary technologies like LiquiXR®, Tris Pharma has developed several leading ADHD therapies aimed at improving patient care. The company focuses on creating high-quality, patient-friendly therapeutics that address unmet medical needs, with a robust pipeline of investigational therapies. Headquartered in Monmouth Junction, NJ, Tris Pharma aims to make significant impacts globally with their transformative treatments.